Diabetes, Vol 47, Issue 10 1549-1554, Copyright © 1998 by American Diabetes Association
Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle
R Napoli, L Gibson, MF Hirshman, MD Boppart, SD Dufresne, ES Horton and LJ Goodyear
Research Division, Joslin Diabetes Center, and Harvard Medical School, Boston, Massachusetts 02215, USA.
Little is known about the regulation of the mitogen-activated protein (MAP)
kinase signaling cascades by hormonal stimulation in vivo. The
extracellular signal-regulated kinase (ERK) and the c-jun kinase (JNK) are
two MAP kinase signaling pathways that could play a role in the cellular
response to hormones such as insulin and epinephrine. We studied the
effects of insulin (20 U/rat) and epinephrine (25 microg/100 g body wt)
injected in vivo on ERK and JNK signaling in skeletal muscle from
Sprague-Dawley rats. Insulin significantly increased ERK phosphorylation
and the activity of its downstream substrate, the p90 ribosomal S6 kinase 2
(RSK2), by 1.4-fold, but it had no effect on JNK activity. In contrast,
epinephrine had no effect on ERK phosphorylation or RSK2 activity, but it
increased JNK activity by twofold, an effect that was inhibited by the
presence of combined alpha and beta blockade. Furthermore, the
phosphorylation of both p46 and p55 isoforms of JNK, measured by
phosphospecific antibody, was increased severalfold. The activity and
phosphorylation of MAP kinase kinase (MKK)-4, an upstream regulator of JNK,
was unchanged by epinephrine. Incubation of isolated soleus muscles in
vitro with epinephrine (10(-5) mol/l) also increased JNK activity by
twofold. These data are the first to demonstrate that epinephrine can
increase JNK activity. Insulin and epinephrine have different effects on
MAP kinase signaling pathways in skeletal muscle, which may be one of the
underlying molecular mechanisms through which these hormones regulate
opposing metabolic functions.